Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a clinic-and-social-media campaign boost HIV prevention among black women?

NCT ID NCT05909176

Completed Prevention Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests a program called Start the Conversation, designed to help Black cisgender women learn about and start taking PrEP—a daily pill that prevents HIV. The program includes training for gynecology residents to discuss PrEP with patients, plus a social media campaign. Researchers will track how many women have the conversation and how many start PrEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this approach could increase PrEP use among Black women, reducing new HIV infections in this community.
What could go wrong
This is a small pilot study (51 participants) focused on implementation, not a large trial measuring HIV prevention directly. Results may not apply to other cities or clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS PREEXPOSURE PROPHYLAXIS

Contacts and locations

Locations

  • Louisiana State University Health Sciences Center

    New Orleans, Louisiana, 70112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.